Page last updated: 2024-08-22

gadolinium and Prostatic Hyperplasia

gadolinium has been researched along with Prostatic Hyperplasia in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's5 (71.43)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acevedo, C; Busel, D; Huidobro, C; Larson, B; Larson, TR; Myers, JJ; Mynderse, LA; Mynderse, S1
Baudendistel, KT; Henry, H; Heverhagen, JT; Jia, G; Knopp, MV; Levine, AL; Polzer, H; Rosol, TJ; von Tengg-Kobligk, H2
Busel, D; Hanson, DP; Huidobro, C; Larson, B; Larson, T; Meyer, JJ; Mynderse, LA1
Barentsz, JO; de la Rosette, JJ; Jager, GJ; Oosterhof, GO; Ruijs, SH; Ruijter, ET; Thornbury, JR; van de Kaa, CA1
El-Diasty, T; Ghoneim, MA; Larson, TR; Osman, YM1
Gevenois, PA; Salmon, I; Simon, J; Sintzoff, SA; Stallenberg, B; Struyven, J; Van Regemorter, G1

Trials

2 trial(s) available for gadolinium and Prostatic Hyperplasia

ArticleYear
Characterizing Prostiva RF treatments of the prostate for BPH with gadolinium-enhanced MRI.
    TheScientificWorldJournal, 2009, Jan-18, Volume: 9

    Topics: Catheter Ablation; Gadolinium; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Prostatic Hyperplasia

2009
Gadolinium-DOTA enhanced MR imaging of prostatic lesions. Preliminary results on 14 cases.
    Journal belge de radiologie, 1992, Volume: 75, Issue:1

    Topics: Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Prostatitis

1992

Other Studies

5 other study(ies) available for gadolinium and Prostatic Hyperplasia

ArticleYear
Benign prostate hyperplasia: evaluation of treatment response with DCE MRI.
    Magma (New York, N.Y.), 2004, Volume: 17, Issue:1

    Topics: Animals; Contrast Media; Dogs; Enzyme Inhibitors; Finasteride; Gadolinium; Heterocyclic Compounds; Kinetics; Magnetic Resonance Imaging; Male; Organometallic Compounds; Prostate; Prostatic Hyperplasia; Time Factors; Treatment Outcome

2004
Pharmacokinetic parameters as a potential predictor of response to pharmacotherapy in benign prostatic hyperplasia: a preclinical trial using dynamic contrast-enhanced MRI.
    Magnetic resonance imaging, 2006, Volume: 24, Issue:6

    Topics: Animals; Contrast Media; Disease Models, Animal; Dogs; Enzyme Inhibitors; Finasteride; Gadolinium; Heterocyclic Compounds; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Microcirculation; Organometallic Compounds; Prospective Studies; Prostate; Prostatic Hyperplasia; Random Allocation; Statistics, Nonparametric; Treatment Outcome

2006
Characterizing TUNA ablative treatments of the prostate for benign hyperplasia with gadolinium-enhanced magnetic resonance imaging.
    Journal of endourology, 2007, Volume: 21, Issue:11

    Topics: Aged; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Prostate; Prostatic Hyperplasia; Transurethral Resection of Prostate

2007
Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results.
    Radiology, 1997, Volume: 203, Issue:3

    Topics: Aged; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Observer Variation; Organometallic Compounds; Pentetic Acid; Prostate; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Subtraction Technique

1997
Correlation between central zone perfusion defects on gadolinium-enhanced MRI and intraprostatic temperatures during transurethral microwave thermotherapy.
    Journal of endourology, 2000, Volume: 14, Issue:9

    Topics: Aged; Aged, 80 and over; Body Temperature; Diathermy; Echo-Planar Imaging; Endosonography; Equipment Design; Gadolinium; Humans; Male; Microwaves; Middle Aged; Prostate; Prostatic Hyperplasia; Reproducibility of Results; Urethra

2000